Digital Technology Changing the Face of Clinical Research

There is a recurring theme that in order for biopharmaceutical companies to have success in the future, change will be necessary as they strive to meet the business challenges of a more complex operating, regulatory, and reimbursement environment.

This article presents the opinions of industry thought leaders – including ERT’s Chief Technology Officer, Don Ragas – on how clinical trial sponsors and CROs are leveraging technology solutions to address the clinical development challenges facing the industry today and in the future.

Read the article below, or download it here.

ERT_Digital_Technology_Changing_Face_of_Clin_Trials_PharmaVOICE_June_2018 (5)
Share